| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PROS.20282 |
| P698 | PubMed publication ID | 16015592 |
| P2093 | author name string | Kazuyo Nakamura | |
| Masami Kusaka | |||
| Takahito Hara | |||
| Masuo Yamaoka | |||
| Jin Kouno | |||
| P2860 | cites work | An overview of animal toxicology studies with bicalutamide (ICI 176,334). | Q34430227 |
| Androgen receptor alterations in prostate cancer relapsed during a combined androgen blockade by orchiectomy and bicalutamide | Q43821771 | ||
| P433 | issue | 3 | |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 268-275 | |
| P577 | publication date | 2005-11-01 | |
| P1433 | published in | The Prostate | Q7758608 |
| P1476 | title | Possible role of adaptive mutation in resistance to antiandrogen in prostate cancer cells | |
| P478 | volume | 65 |
| Q92155807 | A Quantitative and Narrative Evaluation of Goodman and Gilman's Pharmacological Basis of Therapeutics |
| Q39769367 | A mutation in beta-tubulin and a sustained dependence on androgen receptor signalling in a newly established docetaxel-resistant prostate cancer cell line |
| Q34714945 | Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. |
| Q33602374 | Ancient genes establish stress-induced mutation as a hallmark of cancer |
| Q38534949 | Androgen receptor aberrations in the era of abiraterone and enzalutamide |
| Q38915711 | Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets |
| Q38839110 | Drug discovery in advanced prostate cancer: translating biology into therapy |
| Q39078887 | Experimental design to evaluate directed adaptive mutation in Mammalian cells. |
| Q55384150 | Hypothesis: Cancer Is a Disease of Evolved Trade-Offs Between Neoplastic Virulence and Transmission. |
| Q26774221 | Mechanisms of resistance in castration-resistant prostate cancer (CRPC) |
| Q37272639 | Pleiotropic functional properties of androgen receptor mutants in prostate cancer. |
| Q96765854 | SUMO and cellular adaptive mechanisms |
| Q47655848 | Stress-induced cellular adaptive strategies: ancient evolutionarily conserved programs as new anticancer therapeutic targets. |
| Q26795445 | Targeting molecular resistance in castration-resistant prostate cancer |
| Q41991047 | Transcription-associated mutation in Bacillus subtilis cells under stress |
| Q28481716 | Yeasts acquire resistance secondary to antifungal drug treatment by adaptive mutagenesis |
Search more.